Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease attention deficit-hyperactivity disorder
Phenotype C0020179|huntington disease
Sentences 1
PubMedID- 24062308 Tetrabenazine (tbz) is a non-competitive inhibitor of vmat2 that is used in the treatment of hyperkinetic disorders associated with huntington disease and tourette syndrome.

Page: 1